Literature DB >> 2428614

Proto-oncogene c-myc is expressed in cerebellar neurons at different developmental stages.

C Ruppert, D Goldowitz, W Wille.   

Abstract

During post-natal cerebellar development the steady-state levels of c-myc transcripts exhibit characteristic changes. As determined by the S1 nuclease protection assay the level of c-myc transcript, which is very high in the late embryonic cerebellum, decreased to low levels shortly after birth. One week later there is a second period of c-myc mRNA accumulation followed by a marked decline to finally reach the low adult value. The second peak of high c-myc mRNA level correlates well with the proliferation of granule cell precursors, and it is characterized by a marked change in the ratio of the two types of transcripts started at the known c-myc promoters 1 and 2. This indicates a change in the cell population involved in the transcription of the c-myc gene. In situ hybridization shows transiently elevated c-myc mRNA levels in neurons of the cerebellar cortex. At post-natal days 3 and 10 (P3 and P10) c-myc transcripts are detectable in the superficial external granular layer composed primarily of mitotically active (neural precursor) cells. Purkinje cell somata show cytoplasmic label at P10. These large postmitotic neurons undergo rapid differentiation at this developmental stage. In the adult cerebellum the low c-myc mRNA level is apparently due to Purkinje cells with barely detectable amounts of c-myc transcripts. The vast majority of mature cerebellar neurons, the internal granule cells, have no specific hybridization signal for c-myc. We conclude that neurons in vivo can accumulate c-myc messenger during proliferation and/or differentiation, perhaps as a cellular response to an external signal.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428614      PMCID: PMC1167056          DOI: 10.1002/j.1460-2075.1986.tb04442.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  35 in total

1.  Induction of c-fos gene and protein by growth factors precedes activation of c-myc.

Authors:  R Müller; R Bravo; J Burckhardt; T Curran
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

2.  Antibodies to human c-myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation.

Authors:  H Persson; L Hennighausen; R Taub; W DeGrado; P Leder
Journal:  Science       Date:  1984-08-17       Impact factor: 47.728

3.  Transcription and promoter usage of the myc gene in normal somatic and spermatogenic cells.

Authors:  T A Stewart; A R Bellvé; P Leder
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

4.  Microinjected c-myc as a competence factor.

Authors:  L Kaczmarek; J K Hyland; R Watt; M Rosenberg; R Baserga
Journal:  Science       Date:  1985-06-14       Impact factor: 47.728

5.  Coexpression of the sis and myc proto-oncogenes in developing human placenta suggests autocrine control of trophoblast growth.

Authors:  A S Goustin; C Betsholtz; S Pfeifer-Ohlsson; H Persson; J Rydnert; M Bywater; G Holmgren; C H Heldin; B Westermark; R Ohlsson
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

6.  Expression of c-myc changes during differentiation of mouse erythroleukaemia cells.

Authors:  H M Lachman; A I Skoultchi
Journal:  Nature       Date:  1984 Aug 16-22       Impact factor: 49.962

7.  Levels of c-myc oncogene mRNA are invariant throughout the cell cycle.

Authors:  C B Thompson; P B Challoner; P E Neiman; M Groudine
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

8.  C-myc transcript is induced in rat liver at a very early stage of regeneration or by cycloheximide treatment.

Authors:  R Makino; K Hayashi; T Sugimura
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

9.  c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells.

Authors:  S R Hann; C B Thompson; R N Eisenman
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

10.  Specific regulation of c-myc oncogene expression in a murine B-cell lymphoma.

Authors:  J E McCormack; V H Pepe; R B Kent; M Dean; A Marshak-Rothstein; G E Sonenshein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

View more
  25 in total

1.  Interspecies comparison of c-myc gene in human and rat glioma cell lines.

Authors:  H Shindo; E Tani; N Kochi; K Kaba; T Matsumoto; K Miyaji; Y Yamamoto; J Furuyama
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 2.  Genetically engineered murine models--contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma.

Authors:  Louis Chesler; William A Weiss
Journal:  Semin Cancer Biol       Date:  2011-09-21       Impact factor: 15.707

3.  Differential promoter utilization by the c-myc gene in mitogen- and interleukin-2-stimulated human lymphocytes.

Authors:  H E Broome; J C Reed; E P Godillot; R G Hoover
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

Review 4.  Control of myogenic differentiation by cellular oncogenes.

Authors:  M D Schneider; E N Olson
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

5.  Alternative processing of RNA transcribed from NMYC.

Authors:  L W Stanton; J M Bishop
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

6.  Expression and developmental regulation of two unique mRNAs specific to brain membrane-bound polyribosomes.

Authors:  C Hall; C M Lowndes; T K Leung; D N Cooper; A M Goate; L Lim
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

7.  Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse.

Authors:  Kamel Khalili; Luis Del Valle; Vandhana Muralidharan; William J Gault; Nune Darbinian; Jessica Otte; Ellen Meier; Edward M Johnson; Dianne C Daniel; Yayoi Kinoshita; Shohreh Amini; Jennifer Gordon
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  Mice Expressing Myc in Neural Precursors Develop Choroid Plexus and Ciliary Body Tumors.

Authors:  Morgan L Shannon; Ryann M Fame; Kevin F Chau; Neil Dani; Monica L Calicchio; Gwenaelle S Géléoc; Hart G W Lidov; Sanda Alexandrescu; Maria K Lehtinen
Journal:  Am J Pathol       Date:  2018-03-13       Impact factor: 4.307

9.  Analysis of cDNA clones that code for the transmembrane forms of the mouse neural cell adhesion molecule (NCAM) and are generated by alternative RNA splicing.

Authors:  M J Santoni; D Barthels; J A Barbas; M R Hirsch; M Steinmetz; C Goridis; W Wille
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

10.  Repeated CT elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters.

Authors:  E DesJardins; N Hay
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.